Superparamagnetic Iron Oxide-enhanced MRI of Atherosclerotic Plaques in Watanabe Hereditable Hyperlipidemic Rabbits
Overview
Affiliations
Rationale And Objectives: Inflammatory atherosclerotic plaques are characterized by increased endothelial permeability and multiple macrophages. Blood-pool MRI contrast agents like superparamagnetic iron oxide (SPIO) have an affinity for the monocyte-macrophage system and thus, may label inflammatory plaques. The objective was to demonstrate SPIO uptake in plaques of atherosclerotic rabbits by MRI and histology.
Methods: Aortas of anesthetized Watanabe hereditable hyperlipidemic rabbits were studied with a moderately T2*-weighted gradient-echo sequence at 1.5 T. Four groups of five animals each were studied: (1) without ultrasmall SPIO (carboxydextran coating; particle size, 25 nm; estimated plasma half-life, 6 hours) or with imaging after intravenous injection of SPIO at a dose (micromol Fe/kg) and postcontrast time delay (hours) of 50/8 (2), 50/24 (3), or 200/48 (4). In vivo MRI was compared with corresponding ex vivo histological iron stains.
Results: Animals receiving 200 micromol Fe/kg demonstrated areas of focal signal loss clearly confined to the aortic wall on a mean of 24 +/- 9 (31% +/- 11%) of 76 +/- 5 images compared with 0 +/- 0 of 76 +/- 5 images in controls (P = 0.009). The number of images with this finding in groups 2 and 3 was not significantly different compared with controls. By microscopy, SPIO-iron was seen in the endothelial cells and subendothelial intimal macrophages of atherosclerosis-prone aortic wall segments. Atherosclerotic lesions demonstrating iron uptake also showed a high macrophage content.
Conclusions: SPIO accumulates in aortic plaques of atherosclerotic rabbits, producing a characteristic MRI finding. As SPIO accumulates in plaques with increased endothelial permeability and a high macrophage content, two established features of plaque inflammation, it may have a potential for noninvasive assessment of inflammatory atherosclerotic plaques.
Zhang R, Lu K, Xiao L, Hu X, Cai W, Liu L Front Bioeng Biotechnol. 2023; 11:1279446.
PMID: 37811376 PMC: 10557075. DOI: 10.3389/fbioe.2023.1279446.
Biocompatible Iron Oxide Nanoparticles for Targeted Cancer Gene Therapy: A Review.
Zhang J, Zhang T, Gao J Nanomaterials (Basel). 2022; 12(19).
PMID: 36234452 PMC: 9565336. DOI: 10.3390/nano12193323.
VCAM-1 Target in Non-Invasive Imaging for the Detection of Atherosclerotic Plaques.
Thayse K, Kindt N, Laurent S, Carlier S Biology (Basel). 2020; 9(11).
PMID: 33138124 PMC: 7692297. DOI: 10.3390/biology9110368.
Molecular Imaging in Ischemic Heart Disease.
Lavin Plaza B, Theodoulou I, Rashid I, Hajhosseiny R, Phinikaridou A, Botnar R Curr Cardiovasc Imaging Rep. 2019; 12(7):31.
PMID: 31281564 PMC: 6557873. DOI: 10.1007/s12410-019-9500-x.
Fayad Z, Swirski F, Calcagno C, Robbins C, Mulder W, Kovacic J J Am Coll Cardiol. 2018; 72(18):2198-2212.
PMID: 30360828 PMC: 6258199. DOI: 10.1016/j.jacc.2018.08.2150.